CHARLES SCHWAB INVESTMENT MANAGEMENT INC - MOLECULAR TEMPLATES INC ownership

MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 67 filers reported holding MOLECULAR TEMPLATES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of MOLECULAR TEMPLATES INC
ValueSharesWeighting
Q1 2022$349,000
-4.9%
101,000
+7.9%
0.00%
Q4 2021$367,000
-41.6%
93,5890.0%0.00%
Q3 2021$628,000
-70.3%
93,589
-65.4%
0.00%
-100.0%
Q2 2021$2,116,000
-31.4%
270,586
+10.7%
0.00%0.0%
Q1 2021$3,085,000
+50.7%
244,446
+12.2%
0.00%0.0%
Q4 2020$2,047,000
-14.4%
217,909
-0.5%
0.00%0.0%
Q3 2020$2,392,000
+185.8%
218,981
+261.1%
0.00%
Q2 2020$837,000
+22.5%
60,639
+18.0%
0.00%
Q1 2020$683,000
+6.7%
51,372
+12.4%
0.00%
Q4 2019$640,000
+121.5%
45,721
+4.4%
0.00%
Q3 2019$289,000
-21.0%
43,7850.0%0.00%
Q2 2019$366,000
+84.8%
43,785
+29.1%
0.00%
Q1 2019$198,000
+90.4%
33,911
+32.8%
0.00%
Q4 2018$104,000
+13.0%
25,530
+51.1%
0.00%
Q3 2018$92,000
+3.4%
16,9000.0%0.00%
Q2 2018$89,00016,9000.00%
Other shareholders
MOLECULAR TEMPLATES INC shareholders Q2 2022
NameSharesValueWeighting ↓
CAXTON CORP 2,137,991$8,381,0006.85%
ACUTA CAPITAL PARTNERS, LLC 322,500$1,264,0000.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,021,317$4,004,0000.46%
BVF INC/IL 3,129,599$12,268,0000.44%
Bellevue Group AG 10,878,003$42,642,0000.44%
FRAZIER MANAGEMENT LLC 1,374,047$5,386,0000.42%
Endurant Capital Management LP 268,375$1,052,0000.25%
Abingworth LLP 200,000$780,0000.19%
Parkman Healthcare Partners LLC 147,728$579,0000.13%
GSA CAPITAL PARTNERS LLP 145,329$570,0000.07%
View complete list of MOLECULAR TEMPLATES INC shareholders